No other IP Conference Will Provide as Much Strategic Insights on Corporate IP Strategies to Protect Technology & Innovation from Competition Foreign or DomesticBack by popular demand, and with a completely updated 2011 agenda and speaker faculty, ACI s 2nd Advanced China IP Counsel Forum will once again provide you with a practical analysis of notable China IP law developments and best practices for managing your global IP portfolio.
UNPRECEDENTED SPEAKER FACULTYNetwork with an exceptional faculty of in-house IP Counsel and the Who s Who of the IP Bar in China, including senior IP attorneys from Dupont, Intel, Bayer, Pfizer, Johnson & Johnson, Siemens and Philips. Co-chaired by
Jack Chang, Senior IP Counsel Asia for
General Electric and
Oliver Lutz, Head of IPR at
Bayer China, the 2011 agenda features an exceptional line up of senior IP counsel and government officials.
Jim Kellerman, senior patent counsel from
GSK, James Liu, IP Counsel from
ABB and
Xiaobing Feng, Attorney from
ExxonMobil will open the conference with a new panel on
Employment Remuneration Policy and Agreements.The program includes an update from Director Lincun Yang from the Intellectual Property Affairs Center at the Ministry of Science and Technology of PRC on what the Indigenous Innovation policy means for multinational companies.
Xiaman Gu, IP Director from
DSM,
David Shen from
Lilly China and
Benjamin Bai from
JonesDay will share insights on Implementing effective corporate trade secret protection measures and provide the latest on:
- Implementing effective physical corporate security policy
- Using an information security program to prevent the leakage
- What you should be aware of when licensing the technology in China
A highlight of the program is the keynote presentation by Judge Dan Zhu from Shanghai Intermediate Court on practical tips for multinationals in IP litigation!
A 2011 PROGRAM TAILORED FOR YOUR ORGANIZATION/CLIENT S CHALLENGES - Mitigating the risks that employees challenge validity of employment remuneration contracts
- What the indigenous innovation policy means for foreign multinationals
- Justifying core technology owned by the local Chinese entities for HNT enterprise status
- Discussing what are inventions made-in-China in cross-border R&D
- Protecting corporate trade secrets and conducting enterprise-wide training
- Latest update on anti-monopoly law regulatory developments and cases
Benefit from post-conference workshops on
Understanding the Essential IP & Regulatory Framework for Operating Successful and Compliance R&D Centers in China and Collaborative Research Agreements .
Participants will also receive a complimentary CD including all the presentation materials prepared by the speakers particularly for this conference. These materials are an invaluable reference you will be able to use again and again long after the conference is over.
Register now! Call
1-888-224-2480 in the US,
+44 7878 6888 in Europe, or register online at
www.C5-Online.com/ChinaIP
